Several studies suggest that HRV could serve as a predictive marker for treatment outcomes in cancer patients. For instance, lower HRV has been linked to increased mortality and lower survival rates in patients with various types of cancer. Monitoring HRV could help healthcare providers tailor treatment plans and identify patients who may require additional support.
